美西律（Kö 1173）治疗室性心律失常 - Suppr

Suppr

超能文献

Treatment of ventricular arrhythmias with mexiletine (Kö 1173).

作者信息

Talbot R G, Nimmo J, Julian D G, Clark R A, Neilson J M, Prescott L F

出版信息

Lancet. 1973 Aug 25;2(7826):399-404. doi: 10.1016/s0140-6736(73)92270-8.

DOI:10.1016/s0140-6736(73)92270-8

PMID:4124889

Abstract

摘要

相似文献

Treatment of ventricular arrhythmias with mexiletine (Kö 1173).

Lancet. 1973 Aug 25;2(7826):399-404. doi: 10.1016/s0140-6736(73)92270-8.

Mexiletine (Kö 1173) in the management of ventricular dysrhythmias.

Lancet. 1973 Aug 25;2(7826):404-7. doi: 10.1016/s0140-6736(73)92271-x.

Lidocaine (Xylocaine) as an anti-arrhythmic agent.

Med Lett Drugs Ther. 1971 Jan 8;13(1):1-2.

Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.

Int J Cardiol. 1985 Mar;7(3):303-6. doi: 10.1016/0167-5273(85)90056-7.

Aprindine (AC 1802), a new anti-arrhythmic drug.

Acta Cardiol. 1973;28(2):145-65.

Lidocaine as an antiarrhythmic Experience in 68 patients.

Acta Med Scand. 1969 Apr;185(4):297-302.

[Clinical study of the anti-arrhythmia preparation, mexitil].

Kardiologiia. 1980 Oct;20(10):100-2.

Mexiletine and tocainide: does response to one predict response to the other?

J Am Coll Cardiol. 1986 Feb;7(2):338-43. doi: 10.1016/s0735-1097(86)80502-2.

[Treatment of rhythm disorders of ventricular origin with KO 1173 (Mexiletin) (author's transl)].

Med Klin. 1977 Sep 2;72(35):1386-91.

Practolol in the treatment of cardiac dysrhythmias due to acute myocardial infarction.

Lancet. 1969 Aug 2;2(7614):227-30. doi: 10.1016/s0140-6736(69)90001-4.

引用本文的文献

Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective.

Int J Mol Sci. 2025 Jun 2;26(11):5350. doi: 10.3390/ijms26115350.

Comparison of Oral Procainamide and Mexiletine Treatment of Recurrent and Refractory Ventricular Tachyarrhythmias.

J Clin Med. 2024 Oct 13;13(20):6099. doi: 10.3390/jcm13206099.

Relevance of mexiletine in the era of evolving antiarrhythmic therapy of ventricular arrhythmias.

Clin Res Cardiol. 2024 Jun;113(6):791-800. doi: 10.1007/s00392-024-02383-9. Epub 2024 Feb 14.

Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic review.

Europace. 2022 Nov 22;24(11):1809-1823. doi: 10.1093/europace/euac087.

Oral procainamide as pharmacological treatment of recurrent and refractory ventricular tachyarrhythmias: A single-center experience.

Heart Rhythm O2. 2021 Dec 17;2(6Part B):840-847. doi: 10.1016/j.hroo.2021.10.002. eCollection 2021 Dec.

Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.

Neurology. 2021 Jan 12;96(2):e228-e240. doi: 10.1212/WNL.0000000000011002. Epub 2020 Oct 12.

Therapeutic drug monitoring of mexiletine at a large academic medical center.

SAGE Open Med. 2016 Sep 21;4:2050312116670659. doi: 10.1177/2050312116670659. eCollection 2016.

The renal excretion of mexiletine (Kö 1173) under controlled conditions of urine pH.

Br J Clin Pharmacol. 1974 Feb;1(1):86-7. doi: 10.1111/j.1365-2125.1974.tb00214.x.

A case of mexiletine-induced hypersensitivity syndrome presenting as eosinophilic pneumonia.

J Korean Med Sci. 2010 Jan;25(1):148-51. doi: 10.3346/jkms.2010.25.1.148. Epub 2009 Dec 29.

Therapeutic drug monitoring of antiarrhythmic drugs.

Clin Pharmacokinet. 2003;42(7):647-63. doi: 10.2165/00003088-200342070-00004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验